Literature DB >> 11959221

The limitations of calcineurin and mTOR inhibitors: new directions for immunosuppressive strategies.

B D Kahan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11959221     DOI： 10.1016/s0041-1345(01)02702-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Immunosuppression: towards a logical approach in liver transplantation.

Authors:  I Perry; J Neuberger
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

Review 2.  Surgical biology for the clinician: vascular effects of immunosuppression.

Authors:  Elissa Tepperman; Danny Ramzy; Jessica Prodger; Rohit Sheshgiri; Mitesh Badiwala; Heather Ross; Vivek Raoa
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

3.  Rapamycin up-regulates triglycerides in hepatocytes by down-regulating Prox1.

Authors:  Sora Kwon; Ji-Sook Jeon; Su Bin Kim; Young-Kwon Hong; Curie Ahn; Jung-Suk Sung; Inho Choi
Journal:  Lipids Health Dis       Date:  2016-02-27       Impact factor: 3.876

4.  PROX1, a Key Mediator of the Anti-Proliferative Effect of Rapamycin on Hepatocellular Carcinoma Cells.

Authors:  Sora Kwon; Kiwon Ban; Young-Kwon Hong; Jung-Suk Sung; Inho Choi
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

Review 5.  Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?

Authors:  Xiaoyan Liu; Qing Zhou; Yan Xu; Minjiang Chen; Jing Zhao; Mengzhao Wang
Journal:  Oncotarget       Date:  2017-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.